Forced Adult Vaccinations at Federal Levels Comment Period Now#iBelieve#Android#Family

Catherine J. Frompovich
Activist Post

The U.S. Health and Human Services published a 46-page draft proposal and notice in the Federal Register recently regarding more mandated vaccines for adults, and especially pregnant females; employer-enforced adult vaccinations; and probably for getting faith-based groups to uptake and not oppose vaccines/vaccinations.

There is an open public comment period that ends March 9, 2015, for consumers to register their comments, etc. per instructions at this website.

How to file your comments

Electronic responses are preferred and may be addressed to: Rebecca.Fish@hhs.gov.

or

Written responses should be addressed to: National Vaccine Program Office, U.S. Department of Health and Human Services, 200 Independence Avenue SW., Room 733G, Washington, DC 20201. Attn: HHS Adult Immunization c/o Rebecca Fish.

Continue to the Article Here

http://www.activistpost.com

Are Forced Ebola Vaccines Coming To Your Town Soon?#iBelieve#Utah#Ebola

“Cry “Havoc,” and let slip the dogs of war”  

William Shakespeare

There have been many questions regarding the Ebola outbreak and the attempt to have it contained around the world. In light of an article by the WSJ, Tekmira Pharmaceuticals has been placed on the fast track to increase production of their experimental drugs and to expedite clinical trials on infected patients. But, what is the connection between the U.S. government and Tekmira Pharmaceuticals?

If we look back to October 2009, the United States government applied for a patent on Ebola. The patent actually pertains to all variants of Ebola. The patent also seeks ownership over any and all Ebola viruses that are weakened or killed, giving the US government ownership over all Ebola vaccines. This patent monopoly would give the US government the legal right to block all non-vaccine Ebola treatments, cures, or research.

In 2010, the Tekmira Pharmaceutical company signed a $140 million contact with the Department of Defense to advance an RNAI therapeutic to treat the Ebola virus infection. In March of 2014, Tekmira was granted a Fast Tract designation from the FDA for the anti-Ebola viral RNAi therapeutic, which allows for the quick review of the drug in order to get it our to patients more quickly.

“There ‘s daggers in men’s smiles” 

William Shakespeare

However, does this patent allow the federal government to squash any other treatments that might come down the pike?…

Read the Entire Article Here

www.westernjournalism.com